We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$40.3B
AUM Growth
-$1.82B
Cap. Flow
+$332M
Cap. Flow %
0.83%
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$231M
2
GILD icon
Gilead Sciences
GILD
+$113M
3
PCG icon
PG&E
PCG
+$102M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$80.2M
5
ALL icon
Allstate
ALL
+$64.4M

Top Sells

Rank Stock Value
1
V icon
Visa
V
+$472M
2
ABBV icon
AbbVie
ABBV
+$121M
3
VLUE icon
iShares MSCI USA Value Factor ETF
VLUE
+$69.5M
4
CRM icon
Salesforce
CRM
+$64.3M
5
HD icon
Home Depot
HD
+$62.4M

Sector Composition

Rank Sector Weight
1 Technology 20.24%
2 Healthcare 19.03%
3 Financials 13.02%
4 Consumer Discretionary 9.39%
5 Industrials 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGO icon
1701
AngioDynamics
ANGO
$605M
$306K ﹤0.01%
14,960
GDOT icon
1702
Green Dot
GDOT
$750M
$304K ﹤0.01%
16,009
PFS icon
1703
Provident Financial Services
PFS
$3.14B
$304K ﹤0.01%
15,600
AUPH icon
1704
Aurinia Pharmaceuticals
AUPH
$1.95B
$302K ﹤0.01%
40,150
+7,440
+23% +$64.4K
ZUMZ icon
1705
Zumiez
ZUMZ
$330M
$302K ﹤0.01%
14,040
CLDX icon
1706
Celldex Therapeutics
CLDX
$2.94B
$301K ﹤0.01%
10,710
MDGL icon
1707
Madrigal Pharmaceuticals
MDGL
$12.6B
$298K ﹤0.01%
4,580
-8,508
-65% -$591K
VNDA icon
1708
Vanda Pharmaceuticals
VNDA
$304M
$298K ﹤0.01%
30,160
FROG icon
1709
JFrog
FROG
$8.88B
$297K ﹤0.01%
13,430
KYNB
1710
Kyntra Bio
KYNB
$27.4M
$296K ﹤0.01%
910
+142
+18% +$45.7K
B
1711
DELISTED
Barnes Group Inc.
B
$296K ﹤0.01%
10,262
IOT icon
1712
Samsara
IOT
$22.6B
$295K ﹤0.01%
24,430
+6,920
+40% +$98K
MNKD icon
1713
MannKind Corp
MNKD
$1.19B
$292K ﹤0.01%
94,630
+35,890
+61% +$135K
PEGA icon
1714
Pegasystems
PEGA
$5.09B
$292K ﹤0.01%
18,200
+6,180
+51% +$126K
CVGW
1715
DELISTED
Calavo Growers
CVGW
$291K ﹤0.01%
9,152
-2,080
-19% -$83.5K
PYCR
1716
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
$291K ﹤0.01%
+9,850
New +$285K
NVRO
1717
DELISTED
NEVRO CORP.
NVRO
$291K ﹤0.01%
6,240
NEX
1718
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$291K ﹤0.01%
39,380
+32,960
+513% +$289K
RVMD icon
1719
Revolution Medicines
RVMD
$38.5B
$289K ﹤0.01%
14,640
+2,650
+22% +$58.2K
MYOV
1720
DELISTED
Myovant Sciences Ltd.
MYOV
$289K ﹤0.01%
16,100
+6,480
+67% +$103K
DEA
1721
Easterly Government Properties
DEA
$1.16B
$288K ﹤0.01%
7,316
HVT icon
1722
Haverty Furniture Companies
HVT
$418M
$288K ﹤0.01%
11,550
JAMF
1723
DELISTED
Jamf
JAMF
$288K ﹤0.01%
13,000
MTRN icon
1724
Materion
MTRN
$3.94B
$288K ﹤0.01%
3,600
+1,910
+113% +$157K
SLCA
1725
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$288K ﹤0.01%
26,330
-10,960
-29% -$139K

Similar funds

Ensign Peak Advisors's Q3 2022 Portfolio in Review

As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
  • Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
  • Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
  • Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
  • Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
  • Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
  • Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.

Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.